Cisplatine

DRUG2 trials

Sponsors

Lymphoma Study Association, All India Institute of Medical Sciences

Conditions

Head and Neck NeoplasmsLymphoma, Large-Cell, DiffuseSwallowing Sparing IMRT

Phase 3

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

CompletedNCT00137995

Lymphoma Study AssociationLymphoma, Large-Cell, Diffuse

Start: 2003-06-30End: 2008-10-31Updated: 2019-08-28

The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas

RecruitingNCT05187091

All India Institute of Medical SciencesHead and Neck Neoplasms, Swallowing Sparing IMRT

Start: 2021-07-12End: 2026-12-01Target: 136Updated: 2026-05-04

Related Papers

Acute radiation morbidities and dosimetric evaluation of DARS structures: Results from the phase III randomized SWOAR trial.

Journal of Clinical Oncology2024-08-10

P+R‐ICE: PEMBROLIZUMAB IN COMBINATION WITH R‐ICE CHEMOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ‐ ONGOING TRIAL

Hematological Oncology2023-06-01

Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma

Blood Advances2022-01-1420 citations